Immuneering Intangibles To Total Assets from 2010 to 2024

IMRX Stock  USD 2.05  0.03  1.44%   
Immuneering Corp Intangibles To Total Assets yearly trend continues to be fairly stable with very little volatility. Intangibles To Total Assets will likely drop to 0.05 in 2024. Intangibles To Total Assets is the ratio of a company's intangible assets (like goodwill and patents) to its total assets. View All Fundamentals
 
Intangibles To Total Assets  
First Reported
2010-12-31
Previous Quarter
0.06891985
Current Value
0.0453
Quarterly Volatility
0.00750962
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immuneering Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuneering Corp's main balance sheet or income statement drivers, such as Net Interest Income of 3.5 M, Interest Income of 3.5 M or Depreciation And Amortization of 369.7 K, as well as many indicators such as Price To Sales Ratio of 207, Dividend Yield of 0.0 or PTB Ratio of 2.42. Immuneering financial statements analysis is a perfect complement when working with Immuneering Corp Valuation or Volatility modules.
  
Check out the analysis of Immuneering Corp Correlation against competitors.
For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.

Latest Immuneering Corp's Intangibles To Total Assets Growth Pattern

Below is the plot of the Intangibles To Total Assets of Immuneering Corp over the last few years. It is the ratio of a company's intangible assets (like goodwill and patents) to its total assets. Immuneering Corp's Intangibles To Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immuneering Corp's overall financial position and show how it may be relating to other accounts over time.
Intangibles To Total Assets10 Years Trend
Slightly volatile
   Intangibles To Total Assets   
       Timeline  

Immuneering Intangibles To Total Assets Regression Statistics

Arithmetic Mean0.05
Geometric Mean0.05
Coefficient Of Variation16.41
Mean Deviation0
Median0.04
Standard Deviation0.01
Sample Variance0.000056
Range0.0261
R-Value0.53
Mean Square Error0.000044
R-Squared0.28
Significance0.04
Slope0.0009
Total Sum of Squares0.0008

Immuneering Intangibles To Total Assets History

2024 0.0453
2023 0.0689
2022 0.058

About Immuneering Corp Financial Statements

Immuneering Corp investors use historical fundamental indicators, such as Immuneering Corp's Intangibles To Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immuneering Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Intangibles To Total Assets 0.07  0.05 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.